Clinical Trials Browser

OTHER × Fluid Therapy × Plasma cell × Clear all

NCT05847569 2026-02-03

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

Phase 2 Recruiting

Multiple Myeloma